Literature DB >> 16642426

Growth arrest and decrease of alpha-SMA and type I collagen expression by palmitic acid in the rat hepatic stellate cell line PAV-1.

Armand Abergel1, Vincent Sapin, Nicolas Dif, Christophe Chassard, Claude Darcha, Julie Marcand-Sauvant, Brigitte Gaillard-Martinie, Edmond Rock, Pierre Dechelotte, Patrick Sauvant.   

Abstract

Liver fibrosis is characterized by an activation of hepatic stellate cells (HSC). During primary culture HSC evolve from a quiescent into an activated phenotype which is characterized by alpha-smooth muscle actin (alpha-SMA) up-regulation, increase in cell growth, and extracellular matrix secretion. HSC culture with trans-resveratrol can lead to deactivation of myofibroblast-like HSC. We used an HSC line, PAV-1, to check the role of retinol and palmitic acid in the deactivation process of HSC. Using mass and metabolic-based methods, Western blot and immunocytochemistry assays, we demonstrated that treatment with palmitic acid (75 muM) alone or in combination with retinol (2 muM) significantly decreased cell proliferation and alpha-SMA expression. We also established that the association of both compounds strongly decreased collagen type I expression. Our results suggest the potential use of palmitic acid alone or in combination with retinol to induce HSC deactivation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16642426     DOI: 10.1007/s10620-005-9031-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  63 in total

1.  Apoptosis and cytokine release induced by ionizing or ultraviolet B radiation in primary and immortalized human keratinocytes.

Authors:  C Petit-Frère; E Capulas; D A Lyon; C J Norbury; J E Lowe; P H Clingen; E Riballo; M H Green; C F Arlett
Journal:  Carcinogenesis       Date:  2000-06       Impact factor: 4.944

2.  Effects of retinol on proliferation, cell adherence and extracellular matrix synthesis in a liver myofibroblast or lipocyte cell line (GRX).

Authors:  R Margis; M Pinheiro-Margis; L C da Silva; R Borojevic
Journal:  Int J Exp Pathol       Date:  1992-04       Impact factor: 1.925

3.  Expression of retinoic acid receptor and retinoid X receptor subtypes in rat liver cells: implications for retinoid signalling in parenchymal, endothelial, Kupffer and stellate cells.

Authors:  S M Ulven; V Natarajan; K B Holven; T Løvdal; T Berg; R Blomhoff
Journal:  Eur J Cell Biol       Date:  1998-10       Impact factor: 4.492

4.  Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.

Authors:  Kaname Yoshizawa; Daniel P Cioca; Shigeyuki Kawa; Eiji Tanaka; Kendo Kiyosawa
Journal:  Cancer       Date:  2002-11-15       Impact factor: 6.860

5.  Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells.

Authors:  A Galli; D Crabb; D Price; E Ceni; R Salzano; C Surrenti; A Casini
Journal:  Hepatology       Date:  2000-01       Impact factor: 17.425

6.  Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapevine-derived polyphenol.

Authors:  S Godichaud; S Krisa; B Couronné; L Dubuisson; J M Mérillon; A Desmoulière; J Rosenbaum
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Retinyl palmitate reduces hepatic fibrosis in rats induced by dimethylnitrosamine or pig serum.

Authors:  Y Mizobuchi; I Shimizu; M Yasuda; H Hori; M Shono; S Ito
Journal:  J Hepatol       Date:  1998-12       Impact factor: 25.083

Review 9.  Vitamin A hepatotoxicity: a cautionary note regarding 25,000 IU supplements.

Authors:  T E Kowalski; M Falestiny; E Furth; P F Malet
Journal:  Am J Med       Date:  1994-12       Impact factor: 4.965

10.  Treatment of the rat hepatic stellate cell line, PAV-1, by retinol and palmitic acid leads to a convenient model to study retinoids metabolism.

Authors:  Patrick Sauvant; Armand Abergel; Anne Partier; Marie-Cécile Alexandre-Gouabau; Edmond Rock; Benoit Sion; Claude Motta; Vincent Sapin; Véronique Azaïs-Bresco
Journal:  Biol Cell       Date:  2002-10       Impact factor: 4.458

View more
  12 in total

1.  CCl4-induced hepatic injury in mice fed a Western diet is associated with blunted healing.

Authors:  Monique Allman; Latausha Gaskin; Chantal A Rivera
Journal:  J Gastroenterol Hepatol       Date:  2010-03       Impact factor: 4.029

2.  The expression of ETAR in liver cirrhosis and liver cancer.

Authors:  Juhong Deng; Yu Huang; Ran Tao; Xiangxue Fan; Hongyue Zhang; Hongyan Kong; Qiqing Song; Jiaquan Huang
Journal:  Cancer Biol Ther       Date:  2017-08-16       Impact factor: 4.742

Review 3.  Vitamin A and lipid metabolism: relationship between hepatic stellate cells (HSCs) and adipocytes.

Authors:  Patrick Sauvant; Maud Cansell; Claude Atgié
Journal:  J Physiol Biochem       Date:  2011-05-31       Impact factor: 4.158

4.  Nuclear cathepsin F regulates activation markers in rat hepatic stellate cells.

Authors:  Gunter Maubach; Michelle Chin Chia Lim; Lang Zhuo
Journal:  Mol Biol Cell       Date:  2008-07-30       Impact factor: 4.138

5.  Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.

Authors:  Chantal A Rivera; LaTausha Gaskin; Monique Allman; Jia Pang; Kristen Brady; Patrick Adegboyega; Kevin Pruitt
Journal:  BMC Gastroenterol       Date:  2010-05-28       Impact factor: 3.067

6.  Down-regulation of transforming growth factor beta 1/activin receptor-like kinase 1 pathway gene expression by herbal compound 861 is related to deactivation of LX-2 cells.

Authors:  Li Li; Xin-Yan Zhao; Bao-En Wang
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

7.  Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice.

Authors:  Kouichi Miura; Ling Yang; Nico van Rooijen; David A Brenner; Hirohide Ohnishi; Ekihiro Seki
Journal:  Hepatology       Date:  2013-02       Impact factor: 17.425

Review 8.  Experimental models of liver fibrosis.

Authors:  Sara Crespo Yanguas; Bruno Cogliati; Joost Willebrords; Michaël Maes; Isabelle Colle; Bert van den Bossche; Claudia Pinto Marques Souza de Oliveira; Wellington Andraus; Venâncio Avancini Ferreira Alves; Isabelle Leclercq; Mathieu Vinken
Journal:  Arch Toxicol       Date:  2015-06-06       Impact factor: 5.153

9.  Enhanced effect of soluble transforming growth factor-beta receptor II and IFN-gamma fusion protein in reversing hepatic fibrosis.

Authors:  H Yao; J Pan; Y Qian; Z Pei; A Bader; N H Brockmeyer; P Altmeyer; Lihuang Zhang
Journal:  Eur J Med Res       Date:  2010-04-08       Impact factor: 2.175

Review 10.  Immune and inflammatory pathways in NASH.

Authors:  Michal Ganz; Gyongyi Szabo
Journal:  Hepatol Int       Date:  2013-08-30       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.